Regulatory policy as innovation: Constructing rules of engagement for a technological zone of tissue engineering in the European Union
暂无分享,去创建一个
[1] L. Leydesdorff,et al. The dynamics of innovation: from National Systems and , 2000 .
[2] Sibylle Gaisser,et al. Human Tissue Engineered Products - Today's Markets and Future Prospects , 2003 .
[3] L. Hogle. Claims and disclaimers: Whose expertise counts? , 2002, Medical anthropology.
[4] Julie Kent,et al. Human tissue engineered products—drugs or devices? , 2003, BMJ : British Medical Journal.
[5] M. Callon. The Sociology of an Actor-Network: The Case of the Electric Vehicle , 1986 .
[6] J. Abraham,et al. Progress, Innovation and Regulatory Science in Drug Development , 2002, Social studies of science.
[7] Rom Harré,et al. Material Objects in Social Worlds , 2002 .
[8] Alex Faulkner,et al. Medical Technology into Healthcare and Society: A Sociology of Devices, Innovation and Governance , 2008 .
[9] A. Faulkner,et al. Tissue-Engineered Technologies: Scientific Biomedicine, Frames of Risk and Regulatory Regime-Building in Europe , 2008 .
[10] Robert Bud. Resistance to new technology: In the engine of industry: regulators of biotechnology, 1970–86 , 1995 .
[11] Stuart S. Blume,et al. Insight and Industry: On the dynamics of technological change in Medicine Cambridge , 1991 .
[12] Jerry Ravetz. Science and Governance in the European Union. A Contribution to the Debate. , 2000 .
[13] Martin Bauer. Resistance to New Technology: Nuclear Power, Information Technology, Biotechnology , 1995 .
[14] M. Callon. Europe wrestling with technology , 2004 .
[15] D. Vogel. The new politics of risk regulation in Europe , 2001 .
[16] F. Malerba. NEW CHALLENGES FOR SECTORAL SYSTEMS OF INNOVATION IN EUROPE , 2002 .
[17] Julie Kent,et al. Purity and the dangers of regenerative medicine: Regulatory innovation of human tissue-engineered technology , 2006, Social Science & Medicine.
[18] C. Waldby. Stem Cells, Tissue Cultures and the Production of Biovalue , 2002 .
[19] A. Clarke,et al. Biomedicalization: Technoscientific Transformations of Health, Illness, and U.S. Biomedicine , 2003, American Sociological Review.
[20] R. Rhodes. Understanding governance : policy networks, governance, reflexivity and accountability , 1997 .
[21] A. Barry. Political Machines: Governing a Technological Society , 2001 .
[22] Gerard Delanty,et al. Book Review: Rethinking Europe: Social Theory and the Implications of Europeanization , 2006 .
[23] M. Steffen. Health governance in Europe : issues, challenges and theories , 2005 .
[24] Les Levidow,et al. Recasting “Substantial Equivalence”:Transatlantic Governance of GM Food , 2007 .
[25] L. Sharp. Bodies, boundaries, and territorial disputes: Investigating the Murky Realm of scientific authority , 2002, Medical anthropology.
[26] E. Vos. Institutional frameworks of community health and safety legislation : committees, agencies and private bodies , 1999 .
[27] E. Millstone. Science, risk and governance: Radical rhetorics and the realities of reform in food safety governance , 2009 .
[28] P. Glasner. Banking on Immortality? Exploring the Stem Cell Supply Chain from Embryo to Therapeutic Application , 2005 .
[29] M. Callon,et al. Mapping the dynamics of science and technology : sociology of science in the real world , 1988 .
[30] M. Gibbons,et al. Re-Thinking Science: Knowledge and the Public in an Age of Uncertainty , 2003 .
[31] P. Conrad. The Shifting Engines of Medicalization∗ , 2005 .
[32] W. Powell,et al. The New Institutionalism in Organizational Analysis , 1993 .
[33] Julie Kent,et al. Culturing Cells, Reproducing and Regulating the Self , 2006 .
[34] John Abraham,et al. Interpellative Sociology of Pharmaceuticals: Problems and Challenges for Innovation and Regulation in the 21st Century , 2007, Technol. Anal. Strateg. Manag..
[35] A. Faulkner,et al. Towards governance of human tissue engineered technologies in Europe: Framing the case for a new regulatory regime , 2006 .
[36] John Metcalfe,et al. Emergent innovation systems and the delivery of clinical services: The case of intra-ocular lenses , 2005 .
[37] Mike Michael,et al. Regulating Hybrids: ‘Making a Mess’ and ‘Cleaning Up’ in Tissue Engineering and Transpecies Transplantation , 2006, Social theory & health : STH.
[38] J. Abraham,et al. Regulating Medicines in Europe: Competition, Expertise and Public Health , 2000, BMJ : British Medical Journal.
[39] Paul Martin,et al. The Drugs Don't Work , 2003, Social studies of science.
[40] H. Klein,et al. The Social Construction of Technology: Structural Considerations , 2002 .